Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reactivation of EBV for Patients With CAEBV and EBV Associated HLH After Transplantation

NCT04690036 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT04690036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04690036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reactivation of EBV for Patients With CAEBV and EBV Associated HLH After Transplantation
Lead sponsor
Beijing Friendship Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
July 1, 2021
Completion date
January 1, 2023
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ebv infection, pd-1, transplant